A sample report on
Kenya Retail
Pharmacy Market
Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)
www.insights10.com
This report presents a strategic analysis of the Kenya Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Kenya Retail Pharmacy Market, and offers unmatched value, accuracy, and expert insights
Report Scope
Report Attribute
Details
Number of Pages
70-80
Base Year for Estimation
2022
Forecast Period
2023-2030
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Research Approach
Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 3
Table of Content
CONTENT
PG. NO.
1. Retail Pharmacy Overview
12-24
1.1. Overview
1.2. Kenya Overview
1.3. Economic Overview: Kenya
1.4. Retail Pharmacy Market in Kenya
1.5. Pharmaceuticals Market in Kenya
1.6. Healthcare Scenario in Kenya
1.7. Health Insurance Coverage: Kenya
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting
25-30
2.1 Market size and forecasts (Excel and Methodology)
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 4
Table of Content
CONTENT
PG. NO.
2.2. Market Segmentation
2.2.1. By Product
2.2.2. By Therapeutic Area
2.2.3. By Distribution Channel
3. Market Dynamics
31-35
3.1. Market Growth Drivers
3.1.1. Growing Population
3.1.2. Increasing Burden of Communicable Diseases
3.1.3. Rising Government Support
3.2. Market Restraints
3.2.1. Limited Healthcare Infrastructure
3.2.2. Regulatory Challenges
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 5
Table of Content
CONTENT
PG. NO.
3.2.3. Financial Viability
4. Competitive Landscape
36-45
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Goodlife Pharmacy
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Meds Pharmacy
4.2.2.1. Overview
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 6
Table of Content
CONTENT
PG. NO.
4.2.2.2. Product Applications & Services
4.2.2.3. Recent Developments
4.2.2.4. Partnerships Ecosystem
4.2.2.5. Financials (Based on Availability)
4.2.3. Tuskys Pharmacy
4.2.3.1. Overview
4.2.3.2. Product Applications & Services
4.2.3.3. Recent Developments
4.2.3.4. Partnerships Ecosystem
4.2.3.5. Financials (Based on Availability)
4.2.4. Chandarana Pharmacy
4.2.4.1. Overview
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 7
Table of Content
CONTENT
PG. NO.
4.2.4.2. Product Applications & Services
4.2.4.3. Recent Developments
4.2.4.4. Partnerships Ecosystem
4.2.4.5. Financials (Based on Availability)
4.2.5. The Nairobi Women's Hospital Pharmacy
4.2.5.1. Overview
4.2.5.2. Product Applications & Services
4.2.5.3. Recent Developments
4.2.5.4. Partnerships Ecosystem
4.2.5.5. Financials (Based on Availability)
4.2.6. Silvergate Pharmacies
4.2.6.1. Overview
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 8
Table of Content
CONTENT
PG. NO.
4.2.6.2. Product Applications & Services
4.2.6.3. Recent Developments
4.2.6.4. Partnerships Ecosystem
4.2.6.5. Financials (Based on Availability)
4.2.7. Norkan Pharmacy
4.2.7.1. Overview
4.2.7.2. Product Applications & Services
4.2.7.3. Recent Developments
4.2.7.4. Partnerships Ecosystem
4.2.7.5. Financials (Based on Availability)
4.2.8. Haltons Pharmacy
4.2.8.1. Overview
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 9
Table of Content
CONTENT
PG. NO.
4.2.8.2. Product Applications & Services
4.2.8.3. Recent Developments
4.2.8.4. Partnerships Ecosystem
4.2.8.5. Financials (Based on Availability)
4.2.9. Dawa Limited
4.2.9.1. Overview
4.2.9.2. Product Applications & Services
4.2.9.3. Recent Developments
4.2.9.4. Partnerships Ecosystem
4.2.9.5. Financials (Based on Availability)
4.2.10. Alpha Pharmacy
4.2.10.1. Overview
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 10
Table of Content
CONTENT
PG. NO.
4.2.10.2. Product Applications & Services
4.2.10.3. Recent Developments
4.2.10.4. Partnerships Ecosystem
4.2.10.5. Financials (Based on Availability)
5. Reimbursement Scenario
46-53
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
6. Methodology & Scope
54-60
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 11
Kenya Retail Pharmacy Market Analysis
1. Retail Pharmacy Overview
Overview of Global Retail Pharmacy Trends
Retail Pharmacy Industry: Facts and Emerging Trends
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
15% and 30%
138,000
analysis that will be presented in the final
Is regional pharmacies represented of
Is on a per-store basis, retail chains
report
stores and prescription revenue
dispense annually about 50% more
Respectively in US in 2021
than grocers, the next largest
▪
In this section you will get an
prescription dispensers per retail
understanding of the topic, which includes
location in US in 2021
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
>90%
71% and 29%
topic
Retail Pharmacies generate revenue
Is the average sale of retail
from prescription medications in North
pharmacies hospital pharmacies
▪
In order to obtain access to all of the
America
respectively across the Asia
information that you are seeking, you will
need to purchase the final report
40%
▪
Final report will be comprehensive and
of all pharmacies are still
detailed, and it will include data, analysis,
independently owned in North America
trends, and other relevant information
related to the topic or subject matter of
interest
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 13
1.1 Statistics at a Glance: The Burden of Retail Pharmacy in the World (continued)
Europe
~Revenue to reach
$XX Bn by 2027
North America
~ Market Size of
Asia
$XX Bn
-Fastest CAGR
Kenya
Middle East
~Market Size of
Market
$XX Bn
~$XX Bn Market
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 14
1.2 Kenya Overview
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will get an
understanding of the demographics of the
country/region, which includes the
54 Mn
$$106.2 Bn
population, GDP, healthcare expenditure
and other details related to the topic
Is the total
Gross domestic
population of Kenya
product (GDP) of
▪
In order to obtain access to all of the
in 2021
Kenya in 2021
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
20.1 years
$6.5 Bn
detailed, and it will include data, analysis,
Is the median age
Health expenditure in
trends, and other relevant information
in Kenya
Kenya in 2021
related to the topic or subject matter of
interest
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 15
1.3 Economic Overview: Kenya
Population of Kenya, (2020-2030)
GDP of Kenya, (2020-2030)
XX
XX
XX
XX
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population Split (2023)
▪
In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, By Gender
By Age Group
healthcare expenditure and other details related to the topic
▪
In order to obtain access to all of the information that you are 0-14
seeking, you will need to purchase the final report
15-24
Female
Male
▪
Final report will be comprehensive and detailed, and it will 51%
49%
25-54
include data, analysis, trends, and other relevant information 55-64
related to the topic or subject matter of interest
65+
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 16
1.4 Overview of Retail Pharmacy in Kenya
Highlights of Retail Pharmacy in Kenya
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
According to the Private Sector Innovation Programme for Health (PSP4H), 4,000 of the analysis that will be presented in the
country's 12,000 pharmacies are licensed by Kenya's Pharmacy and Poisons Board final report
(PPB) in Kenya
▪
In this section you will get an
understanding of the topic, which
Kenya Pharmaceutical Association (KPA) is a professional group of regulated includes the prevalence of the disease,
pharmaceutical technologists with a membership of 7,500 of which 3,200 are community the application of medical devices, new
pharmacists who either own or manage their stores
technology, and other details related to
the topic in Kenya
Kenya Pharmaceutical Association (KPA) is a professional group of regulated
▪
In order to obtain access to all of the
pharmaceutical technologists with a membership of 7,500 of which 3,200 are community information that you are seeking, you
pharmacists who either own or manage their stores
will need to purchase the final report
Kenya’s Pharmacy & Poisons Board (PPB) is actively involved in regulating and enhancing
▪
Final report will be comprehensive and
the sector from a quality perspective, in 2011, for example, an estimated 20-25% of drugs detailed, and it will include data,
sold in the country were counterfeit
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 17
1.5 Pharmaceuticals in Kenya
Kenya Pharmaceuticals Market Forecast, 2022-2030 (in $Bn) XX
XX
XX
XX
XX
XX
XX
XX
XX
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In this section you will get an understanding of the overall Pharmaceuticals market in Kenya, which includes the market size, current trends and other details related to the topic
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 18
1.6 Healthcare Scenario in Kenya
▪
Kenya's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall coordination of the sector
o Public healthcare services are offered through government hospitals, health centers, and dispensaries o Private healthcare facilities are operated by non-governmental organizations (NGOs), faith-based organizations, and for-profit entities
▪
Kenya's healthcare system is a mix of public and private providers. The Ministry of Health is responsible for policy formulation and overall coordination of the sector
▪
Universal Health Coverage (UHC): UHC program to provide affordable healthcare to all Kenyan citizens. The aim is to gradually expand coverage and reduce the financial burden of healthcare
▪
Healthcare Workforce Development: Steps have been taken to address the shortage of healthcare professionals by training and hiring more doctors, nurses, and other healthcare workers. Additionally, efforts have been made to deploy health workers to rural areas Key aspects related to pharmaceutical management in Kenya Regulatory
▪
Pharmacy and Poisons Board (PPB) is the regulatory authority responsible for ensuring the quality, safety, and Authority
efficacy of pharmaceutical products in Kenya.
Drug Registration
▪
PPB is responsible for the registration of pharmaceutical products in Kenya Procurement and
▪
Public procurement and distribution of pharmaceutical products in Kenya are primarily managed by the Kenya Distribution
Medical Supplies Authority (KEMSA)
▪
PPB conducts quality control inspections of pharmaceutical manufacturing facilities to ensure compliance with Quality Control
Good Manufacturing Practices (GMP)
▪
In Kenya, the Pharmacovigilance Directorate under the Pharmacy and Poisons Board is responsible for Pharmacovigilance
monitoring and reporting adverse drug reactions and ensuring the safety of pharmaceutical products A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 19
1.7 Health Insurance Coverage: US
% of People by Type of Health Insurance Coverage
Number of People By Health Insurance Coverage
(2021)
Coverage Type
2020
2021
Change %
Uninsured
8.3
Total
327,521
328,074
With health insurance
91.7
Any health plan
299,230
300,887
0.4
Any private plan
217,896
216,366
–0.6
Any private plan
66.0
Employment-based
178,737
178,285
–0.2
Employment-based
54.3
Direct-purchase
10.2
Direct-purchase
33,869
33,555
–0.1
Marketplace
3.5
Marketplace coverage
10,924
11,389
0.1
TRICARE
2.5
TRICARE
9,165
8,299
–0.3
Any public plan
112,925
117,095
1.2
Any public plan
35.7
Medicare
58,541
60,226
0.5
Medicare
18.4
Medicaid
58,778
61,940
0.9
Medicaid
18.9
VA and CHAMPVA
2,967
3,151
0.1
VA and CHAMPVA
1.0
Uninsured
28,291
27,187
–0.4
▪
In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year
▪
More people had private health insurance (66%) than public coverage (35.7%)
▪
Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 20
1.8 Budget of Kenya Government for Public Insurance
Proposed Budget By Category
Outlays
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2022-31
Medicare
$769
$709
$766
$841
$840
$947
$1,014
$1,085
$1,227
$1,178
$1,325
$1,412
$10,633
In Billions Of Dollars
Medicaid
$458
$521
$571
$582
$616
$645
$674
$698
$734
$768
$801
$837
$6,926
Medicare
3.7%
3.2%
3.3%
3.4%
3.3%
3.6%
3.7%
3.8%
4.1%
3.8%
4.1%
4.2%
3.7%
As % Of GDP
Medicaid
2.2%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.5%
2.5%
2.5%
2.5%
2.4%
▪
National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪
Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪
Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪
Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪
Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪
Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪
Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪
Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪
Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪
Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 21
1.9 Mergers and Acquisitions
RCM M&A Deal Value Trend ($Bn)
RCM M&A Deal Volume Trend
$16.7
112
107
107
110
89
$11.7
82
$10.5
$7.7
$6.8
$6.0
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
Buyer Composition: Strategic Vs Financial (2020)
Buyer Type by Deal Size
41%
41%
42%
39%
($Mn)
59%
59%
58%
61%
Strategic Buyers
Financial Buyers
$0- $25
$25-$50
$50-$100
$100+
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 22
1.9 Mergers and Acquisitions (continued)
Latest Deals In Kenya
Amount /
Company Name
Type
Year
Key Pointers
Duration
▪
AmerisourceBergen and Walgreens Boots Alliance entered into a Walgreens Boots
strategic alliance
Alliance Healthcare
Acquisition
January
Business was
-
2021
▪
Walgreens Boots Alliance Healthcare Business was acquired by acquired by
AmerisourceBergen, enabling it to increase its focus on growing AmerisourceBergen
retail pharmacy business
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 23
1.9 Mergers and Acquisitions(continued)
Latest Deals In Kenya
Amount /
Company Name
Type
Year
Key Pointers
Duration
Merger
-
Acquisition
-
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 24
Kenya Retail Pharmacy Market Analysis
2. Market Size and Forecasting
2.1 Market size and forecasts (Excel and Methodology)
Click on the icon to know the
Kenya Retail Pharmacy Market Forecast, 2022-2030 (in $Bn) methodology and assumption
▪
Please be aware that this sample report
XX
is intended to provide you with a brief
XX
overview of the kind of information and
analysis that will be presented in the
final report
▪
In this section you will get an
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
and other details related to the topic
2023
2024
2025
2026
2027
2028
2029
2030
▪
In order to obtain access to all of the
Major Markets Patient
2.74
2.82
2.90
2.94
2.98
3.02
3.07
3.12
information that you are seeking, you
(Mn)
will need to purchase the final report
Kenya Patient Size (Bn)
0.51
0.61
0.68
0.69
0.70
0.71
0.72
0.73
▪
Final report will be comprehensive and
% of US Patients
18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
detailed, and it will include data,
analysis, trends, and other relevant
Global Market Size (Bn $)
3,620
3,780
3,950
4,128
4,314
4,508
4,711
4,937
information related to the topic or
subject matter of interest
Kenya Market Size (Bn $)
61
74
84
87
91
95
99
106
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 26
2.2 Snapshot of Retail Pharmacy Market Segmentation
By Product
By Therapeutic Area
By Distribution Channel
Prescription Drugs
Anti-Infective
Online Pharmacy
Over-the-Counter
Cardiovascular
Hospital Pharmacy
Medications
Vitamins &
Vitamins/Minerals/Nu
Community Pharmacy
Supplements
trients
Medical
Equipment
Pain/Analgesics
Antibiotic
Dermatology
Neurology
▪
In this section you will get an understanding of the segmentations which will cover the Kenya Retail Pharmacy Market
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 27
2.2.1 Market Segmentation: By Product Type
Kenya Retail Pharmacy Market Share, By Product Type (2022)
▪
Prescription drug market in Kenya is a
significant component of the overall
Medical Equipment
Retail Pharmacy treatment market
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
Vitamins &
Supplements
final report
Prescription
▪
In order to obtain access to all of the
Drugs
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
Over-the-Counter
subject matter of interest
Medications
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 28
2.2.2 Market Segmentation: By Retail Pharmacy Type
Kenya Retail Pharmacy Market Share, By Therapeutic Area (2022)
▪
Anti-infective segment in Kenya is a
significant component of the overall
Neurology
Retail Pharmacy market
Dermatology
▪
It has the maximum market share in
Kenya Retail Pharmacy Market with
Anti-Infective
Antibiotic
approximately xx%
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Pain/Analgesics
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
Vitamins/Mineral
s/Nutrients
▪
Final report will be comprehensive and
detailed, and it will include data,
Cardiovascular
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 29
2.2.3 Market Segmentation: By End User
Kenya Retail Pharmacy Market Share, By End User (2022)
▪
Online Pharmacy have the maximum
market share in Kenya Retail
Pharmacy Market with approximately
Community
xx%
Pharmacy
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
Online Pharmacy
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
Hospital
subject matter of interest
Pharmacy
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 30
Kenya Retail Pharmacy Market Analysis
3. Market Dynamics
3.1 Market growth drivers
3.1.1 Current population of Kenya in 2023 is 55,100,586, a 1.99% increase from 2022. In 2022 was 54,027,487, a 1.93%
increase from 2021 and in 2021 was 53,005,614, a 1.96% increase from 2020
▪
Kenya has a rapidly growing population, which directly contributes to Population growth in Kenya
increased demand for healthcare services, including pharmaceutical products.
▪
As the population grows, the need for accessible retail pharmacies expands to cater to the healthcare needs of the growing number of people.
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 32
3.1 Market growth drivers
3.1.2 In Kenya 78.3% of total DALYs are constituted by years of live lost (YLL) due to premature mortality, with the leading causes HIV/AIDS, lower respiratory infections, diarrheal diseases, tuberculosis, and malaria
▪
Prevalence of diseases such as malaria, HIV/AIDS, tuberculosis, Burden of communicable diseases in Kenya
diabetes, and cardiovascular diseases drives the demand for pharmaceutical products
▪
Retail pharmacies play a crucial role in providing access to essential medicines and managing chronic conditions, contributing to the growth of the market
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 33
3.1 Market growth drivers (continued)
3.1.2 Government of Kenya has made efforts to expand health insurance coverage, such as the National Health Insurance Fund (NHIF) and private health insurance schemes
▪
With a growing number of individuals covered by health insurance, more people have access to healthcare services, including prescription medicines
▪
This expanded access to healthcare services drives the demand for pharmaceutical products, benefiting the retail pharmacy market
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 34
3.2 Market restraints
3.2.1 Kenya's rural areas are often
3.2.2 Regulatory environment in Kenya
3.2.3 Limited purchasing power in
characterized by remote and
can pose challenges for retail
rural and underserved areas can pose
geographically challenging terrain,
pharmacies due to the time-consuming
financial challenges for retail
including mountainous regions and
nature of compliance with regulatory
pharmacies
vast distances
requirements
▪
Kenya faces challenges in terms
▪
The regulatory environment in
▪
Establishing and sustaining a
of limited healthcare
Kenya can present challenges
pharmacy business requires a
infrastructure, particularly in rural
for retail pharmacies
certain level of financial viability,
and underserved areas
▪
Compliance with regulatory
which can be challenging in
▪
Lack of adequate healthcare
requirements, such as licensing,
areas with a small customer
facilities and trained personnel
registration, and quality
base and low income levels
can restrict the growth of the
standards, can be demanding
▪
Lack of financial viability makes it
retail pharmacy market, as it
and time-consuming
less attractive for entrepreneurs
becomes challenging to establish
▪
Strict regulations and
to invest in retail pharmacies in
and operate pharmacies in these
bureaucratic processes can
these areas, further hindering
areas
impede the establishment and
their growth
growth of retail pharmacy
businesses
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 35
Kenya Retail Pharmacy Market Analysis
4. Competitive Landscape
4.1 Major Market Share
Revenue of Major players in Kenya Retail Pharmacy Market ($ Mn)
▪
Kenya Retail Pharmacy Market is a highly
competitive space, with many companies
developing and marketing Retail Pharmacy
Company10
treatments
Company 9
▪
Some of the top companies in Kenya Retail
Pharmacy Market based on revenue and
Company 8
market share include
Company 7
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Company 5
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
Company 3
related to the topic or subject matter of
interest
Company 2
Company 1
XX
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 37
4.2 Key Company Profile
Key Note:
1
▪
Here is the list of top 10 companies which
Goodlife Pharmacy
will cover in the final report
2
Meds Pharmacy
▪
Each company will have slides for
o Overview
3
Tuskys Pharmacy
o Key details
4
Chandarana Pharmacy
o Offerings
o Name of products
5
The Nairobi Women's
o Recent activities/ Press Coverage
Hospital Pharmacy
o Distribution and Vendor Partners
6
Silvergate Pharmacies
o Mergers, Acquisitions and
Collaboration
7
Norkan Pharmacy
o Financials
8
▪
If there are specific companies that you
Haltons Pharmacy
would like to be included in the report,
please let us know via email
9
Dawa Limited
▪
In order to obtain access to all of the
information that you are seeking, you will
10
Alpha Pharmacy
need to purchase the final report
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 38
4.2.1 Goodlife Pharmacy
Solutions offered by Roche
▪ Goodlife Pharmacy is one of the largest retail pharmacy chains Founded in: 2014
in Kenya
➢ Amaan Khalfan- Chief Executive
HQ: Nairobi, Kenya
▪
Officer
They operate multiple outlets across the country, offering a wide range of pharmaceutical products, over-the-counter
➢ Justin Melvin- Chief Operations
Type: Private
medications, personal care products, and health services
Officer
▪ Company provides trusted pharmaceuticals to customers
➢ Kamau Munyoroku- Acting Chief
Revenue: $84.4 Mn
across the population from convenient locations with a total Finance Officer
reach of over 2 Mn people with more than 120 branches in the Website: www.goodlife.co.ke/
➢ Yvonne Samantha Achieng-
region
Head of Marketing
Goodlife Pharmacy Services
Recent Activity / Press Coverage
Prescription Medications
Over-the-Counter (OTC) Drugs
▪
June 2021, Goodlife Pharmacy Gives East African Moms Peace of Mind with THINKMD’s Technology That “Thinks” Like a Doctor
Health and Wellness Products
Health Screenings
▪
2022, Goodlife Pharmacy is the largest healthcare provider and the #1
pharmacy chain in East Africa with over 70 stores in both Kenya and Family Planning and Sexual
Home Delivery and Online
Uganda
Health
Ordering
▪
They are accredited by the pharmaceutical board as providers of genuine, quality products and have a broad range of products with a Vaccinations
Clinical Services
portfolio ranging from: Skincare/dermatological products, supplements & multivitamins, personal care and beauty products, as well all prescription Medication Management
Medical Equipment and Devices
medication
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 39
4.2.1 Goodlife Pharmacy (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Type
Year
Key Pointers
Duration
▪
CFAO Healthcare Acquires 30% Stake in Goodlife Pharmacies
from LeapFrog Investments as Part of Strategic Partnership March,
▪
Combination of Goodlife’s retail pharmacy network & brand, and Collaboration
-
CFAO acquire 30%0f
2023
CFAO Healthcare’s existing wholesale distribution capabilities & stake of Goodlife
portfolio products will create strong synergies beneficial to the Pharmacy
business, the market, and the general public
▪
International Finance Corporation (IFC) has backed Goodlife Pharmacy for a stake in Nairobi-based Africa Greatness
Pharmacy sustaining its acquisition streak as it seeks control of Goodlife acquire
Kenya’s retail pharmaceutical space
February
Greatness Pharmacy
Acquisition
-
2022
▪
Nairobi-based Africa Greatness Pharmacy has a turnover of more than Sh1 billion and assets worth over Sh81 Mn with an office in Spring Valley.
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 40
4.2.1 Goodlife Pharmacy (continued)
Revenues ($Bn), 2020-2030
▪
According to Goodlife Pharmacy’s 2022
financial report, the company had sales of
$XX Bn in 2022
70.9
▪
70.3
This is equivalent to approximately $XX Bn
USD, based on exchange rates at the end
63.3
of 2020
▪
Revenue generated by Goodlife Pharmacy
Health in 2022 reflects the company's
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
continued growth and success in the
healthcare industry
Breakdown of Net Revenue by Segment, 2022
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
1
2
3
4
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 41
4.2.2 Company 2
Solutions offered by Company
Founded in:
HQ:
Type:
Revenue:
Website:
Drugs for Retail
Recent Activity / Press Coverage
Pharmacy
Drugs
Indications
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 42
4.2.2 Company 2 (continued)
Partnerships Ecosystem
Major Distribution Partners
Major Vendor Partners
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 43
4.2.2 Company 2 (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 44
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
xx
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 45
Kenya Retail Pharmacy Market Analysis
5. Reimbursement Scenario
5.1 Reimbursement Regulation in Kenya
In Kenya, pharmacy medication reimbursement is primarily facilitated through Public and Private Health Insurance
health insurance schemes and government programs.
Coverage in Kenya
▪
National Hospital Insurance Fund (NHIF):
o NHIF is a government-run health insurance scheme in Kenya. Under Out-of-Pocket
this program, eligible members contribute to the fund, and in return, they Employer-Payments
sponsored
receive access to healthcare services, including reimbursement for Health
pharmacy medications
Insurance
National Hospital
o NHIF covers a wide range of prescription medications, and members Insurance Fund
(NHIF)
can obtain them at designated pharmacies upon presentation of a valid NHIF card
▪
Private Health Insurance:
o Many private health insurance providers in Kenya offer coverage for pharmacy medications as part of their health insurance plans o The extent of coverage and reimbursement varies depending on the specific insurance policy
o Individuals with private health insurance can usually claim reimbursement for prescribed medications by submitting the necessary documentation, such as invoices or receipts, to their insurance Private
Government
Health
company
Health Programs
Insurance
Health Insurance Coverage, 2022
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 47
5.1 Reimbursement Regulation (continued)
▪
Government Health Programs:
o Kenyan government implements various health programs that may include medication reimbursement for specific populations or health conditions. For example, the government provides free antiretroviral therapy (ART) medications for individuals living with HIV/AIDS through the National AIDS Control Council (NACC) o Additionally, the government may subsidize or provide free medications for specific diseases or conditions as part of targeted health interventions
▪
Employer-sponsored Health Insurance:
o Some employers in Kenya provide health insurance coverage for their employees, which may include reimbursement for pharmacy medications
o Coverage and reimbursement terms are determined by the specific insurance plan offered by the employer
▪
Out-of-Pocket Payments:
o It's important to note that not all pharmacy medications are reimbursed, and individuals may need to pay out-of-pocket for certain medications that are not covered by insurance schemes o Additionally, some insurance plans may have limitations or exclusions for certain medications or require co-payments or deductibles
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 48
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population)
Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
100%
100%
100%
100%
100%
0%
Government Expenditure
0%
xx
xx
xx
xx
xx
7%
Public Healthcare
44.
0%
8%
46.
47.
51.
51.
Private Health Insurance
Coverage
Out of Pocket
Private Coverage
9%
1%
6%
5%
5%
38.
37.
35.
32.
31.
Other
NA
NA
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid
6.3%
4.08%
5.1%
3.8%
2.2%
2.4%
3.6%
GDP Growth (yoy)
Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 14.7%
11.3%
15.5%
7.5%
4.2%
NA
NA
HC Spend Growth (yoy)
Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources
Reimbursement Market Trends
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 49
5.2 Reimbursement Process for Retail Pharmacy
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule
▪
Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 50
5.3 Reimbursement Process for Retail Pharmacy
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare FDA
provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a Market Authorization
service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service Private Payers
Public Payers
provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment Health Technology Assessment
provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other 1
2
3
payer reimburses the healthcare provider for the service provided, Coding
Coverage
Payment
based on the negotiated payment rates or fee schedule
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 51
5.4 Reimbursement Process - Medicare
Medicare
▪ 100% population is covered under this scheme
Population Covered
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an individuals Medicare account
Provider Restrictions/
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community Selection
center and over 100 surgery centers, Retail Pharmacy centers, colonoscopy centers and screening centers)
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits Services Covered
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures Level of Coverage/ Assurance
▪ Outpatient scans/ diagnostics for Retail Pharmacy up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient
▪ Renal Retail Pharmacy up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
▪ DRG with Activity Based Funding for public providers
Mechanism of Coverage
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility
▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 52
5.5 Reimbursement Process - Medicaid
Medicaid
▪ 38% population is covered under this scheme
Population Covered
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease Provider Restrictions/
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community Selection
center and over 100 surgery centers, Retail Pharmacy centers, colonoscopy centers and screening centers)
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits Services Covered
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures Level of Coverage/ Assurance
▪ Outpatient scans/ diagnostics for Retail Pharmacy up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient
▪ Renal Retail Pharmacy up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
▪ DRG with Activity Based Funding for public providers
Mechanism of Coverage
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility
▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account Illustrative
A Sample Report on Kenya Retail Pharmacy Market Analysis I Confidential 53
Kenya Retail Pharmacy Market Analysis
6. Methodology & Scope
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Data
Market Data Analysis
Interpretation &
Collection
& Statistical Model
Presentation
Secondary
Analysis &
Market Trends
Research
Interpretation
Primary
Market Sizing &
Insights
Research
Analysis
Proprietary
Data Triangulation &
Presentation &
Database
Validation
Reporting
Data Triangulation & Data Validation
Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary Interview
Revenue generated by products &
Final
services offered by companies
Summary
Bottom Up Approach
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2022
Estimation
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
Customized Report
that is currently not a part of our scope as a
2023-
Forecast
